Skip to content
★ Sign in to follow
LN

Luoyang Northglass Technology Co.,Ltd Stock: price and insider trades · China

北玻股份

CN·Mcap CN¥3.5BIndustrials

No insider purchase over the last 90 days. The latest, by 高一丁, was filed 27 Sept 2024.

Luoyang Northglass Technology Co.,Ltd: what insiders have been doing

Luoyang Northglass Technology Co.,Ltd, classified in the Industrials sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Luoyang Northglass Technology Co.,Ltd. The previous disclosure was published on 27 September 2024.

Since 2021, the database holds 1 purchase and 14 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Auroora Yhtiöt Oyj and MBB SE. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
15
Thresholds
n/a
Buy Volume
€136
1 ops. · all time
Sell Volume
€20M
14 ops. · all time

Since the insiders bought

  • Filed 27 Sept 2024 · 774 days ago · €136
    +4.3%
    Entry CN¥3.91 · Close at T+365 CN¥4.08

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 19,230 of 26,911 companies
37.1
score / 100
Value
24
Quality
50
FCF yld-3.8%
Earn yld0.9%
EV/EBITDA30.8x
ROE-0.3%
Gross mgn27%
Net mgn2.0%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥3.18
Analyst consensus
·
Income statement
RevenueCN¥1.6B
Gross profitCN¥422.7M27% margin
EBITDACN¥113.9M7% margin
Net incomeCN¥31.4M-0.7% margin
Valuation
PER (trailing)321.0x
P/Book1.6x
Beta0.63
Balance sheet & cash
Market capCN¥3.5B
Total debtCN¥4.1M
Free Cash Flow-CN¥134.4M
Debt / Equity0%
Profitability & ownership
ROE-0.3%
ROA-0.5%
% insiders47.6%
% institutions0.4%
Last declaration on 27 September 2024
Declarations15 total
  • ▲
    副总经理Executives
    1,065 CNY30SZSE
    300 shares100.0% of flowA股XSHESZSE:173000008139549000
    Canonical exit: 26 Dec 2024 (T+90)
  • ▼
    董事Executives
    53,636 CNY7SZSE
    9,200 shares0.0% of flowA股XSHESZSE:173000006267119520
  • ▼
    董事Executives
    2M CNY7SZSE
    370,000 shares1.4% of flowA股XSHESZSE:173000006259055800
  • ▼
    董事Executives
    9M CNY8SZSE
    1,981,400 shares6.1% of flowA股XSHESZSE:173000006159319600
  • ▼
    董事Executives
    25M CNY9SZSE
    5,544,600 shares17.3% of flowA股XSHESZSE:173000006004778050
  • ▼
    董事Executives
    8M CNY8SZSE
    1,762,900 shares6.1% of flowA股XSHESZSE:173000005904277820
  • ▼
    董事Executives
    3M CNY7SZSE
    726,000 shares2.5% of flowA股XSHESZSE:173000005902043740
  • ▼
    董事Executives
    3M CNY7SZSE
    586,900 shares2.0% of flowA股XSHESZSE:173000005899365540
  • ▼
    董事Executives
    1M CNY7SZSE
    200,000 shares1.0% of flowA股XSHESZSE:173000005528385630
  • ▼
    董事Executives
    2M CNY7SZSE
    360,000 shares1.5% of flowA股XSHESZSE:173000005378713020
  • ▼
    董事Executives
    30M CNY9SZSE
    7,290,000 shares21.4% of flowA股XSHESZSE:173000005367414180
  • ▼
    董事Executives
    26M CNY9SZSE
    5,725,700 shares18.2% of flowA股XSHESZSE:173000005522888860
  • ▼
    董事Executives
    17M CNY8SZSE
    4,530,000 shares11.0% of flowA股XSHESZSE:173000004583339000
  • ▼
    董事Executives
    11M CNY8SZSE
    2,999,900 shares7.0% of flowA股XSHESZSE:173000004580282980
  • ▼
    董事Executives
    7M CNY7SZSE
    1,838,800 shares4.5% of flowA股XSHESZSE:173000004577029860

15 of 15 declarations

About Luoyang Northglass Technology Co.,Ltd

北玻股份 is a company specializing in the manufacturing of glass and glass products. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations